The co-chief executive's comments coincide with a raft of Japanese buyout funds returning to market to capitalise on rising investor demand.
Though investors seem increasingly drawn to the market's favourable demographic tailwinds, DPI, exit routes and GP selection remain key considerations for potential entrants.
China funds are trading at a 50% discount to NAV even after a decline in private markets valuations, managing director Kent Chen tells PEI.
Dealmaking is due for a comeback this year with the return of financial sponsors and more demand for liquidity, according to a panel at IPEM Cannes.
Buyers need to understand the fundamentals of Chinese secondaries before evaluating discounts, according to Coller Capital’s Zhan Yang.
Covenants and leverage are much tighter in loans to sponsors across the region, according to head of APAC private credit Celia Yan.
The acquisition lays the foundation for a one-stop shop for clients of both organisations, Andy Lund and Matt Swain tell PEI.
GP stakes, healthcare and Middle Eastern investors will be front of mind for Asia-Pacific markets in 2024.
Though GP stakes transactions have been few and far between in the region, a growing number of participants are setting up shop in APAC.
Such is the pace of private equity consolidation that one in six global asset managers will be gone by 2027, according to PwC.